China Universal Asset Management Co., Ltd. Vanda Pharmaceuticals Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 11,045 shares of VNDA stock, worth $57,875. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,045
Previous 11,045
-0.0%
Holding current value
$57,875
Previous $45,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding VNDA
# of Institutions
148Shares Held
49.6MCall Options Held
49.1KPut Options Held
107K-
Black Rock Inc. New York, NY8.14MShares$42.7 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.28MShares$22.4 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$17.8 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.37MShares$12.4 Million0.03% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.8MShares$9.45 Million0.01% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $296M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...